CAD 0.03
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.02 CAD | -9.4% |
2022 | -0.01 CAD | 41.8% |
2021 | -0.03 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.00 CAD | -420.0% |
2024 Q3 | -0.00 CAD | -75.0% |
2024 Q1 | 0.00 CAD | 113.16% |
2023 FY | - CAD | -9.4% |
2023 Q4 | -0.00 CAD | -58.33% |
2023 Q3 | -0.00 CAD | 56.36% |
2023 Q2 | -0.01 CAD | -19.57% |
2023 Q1 | -0.00 CAD | -15.0% |
2022 FY | - CAD | 41.8% |
2022 Q3 | -0.00 CAD | 0.0% |
2022 Q2 | -0.00 CAD | -86.96% |
2022 Q4 | -0.00 CAD | 6.98% |
2022 Q1 | -0.00 CAD | 88.08% |
2021 Q1 | -0.00 CAD | 0.0% |
2021 Q4 | -0.02 CAD | -328.89% |
2021 Q3 | -0.00 CAD | -350.0% |
2021 Q2 | -0.00 CAD | 0.0% |
2021 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AI/ML Innovations Inc. | -0.06 CAD | 71.201% |
Pangenomic Health Inc. | -0.30 CAD | 94.567% |
nDatalyze Corp. | -0.00 CAD | -307.5% |
Treatment.Com International Inc. | -0.26 CAD | 93.731% |
Unidoc Health Corp. | -0.04 CAD | 63.697% |